News
Kazakhstan Ministry of Health Officials Visited Our Biotechnology Facilities
We hosted the officials of the Ministry of Health of Kazakhstan at our biotechnology facilities hosted by our General Manager Oğuz Akandil, Business Development Directors Sem...
We participated DCAT week events in New York
We participated the event held in New York, USA between March 21-24, with Hasan Ulusoy, our Chairman of the Board, Berkant Köseoğlu, Ulkar Kimya General Manager, Semih Durmuş, Nobel İlaç Business Developmen...
Award for Nobel İlaç on the 30th Anniversary of Kazakhstan's Independence
Recently, a special ceremony was held at the Almaty Republic Palace to mark the 30th anniversary of Kazakhstan's Independence.
The Trick Is Not To Save The Day, But To Seize The Future
Providing information about Nobel İlaç's organizational structure, R&D approach and investments, Nobel İlaç and Ulkar Holding Chairman Hasan Ulusoy shared his views on the development areas of ...
Belgin Işık, Our Supply Chain Manager received Turkey's Most Influential Supply Chain Professionals Award
Belgin Işık, Our Supply Chain Manager received Turkey's Most Influential Supply Chain Professionals Award
Oğuz Akandil Appointed As General Manager Of Nobel İlaç Turkey
Working in the pharmaceutical industry in various domestic and abroad positions for many years, Oğuz Akandil was appointed as the General Manager of Nobel İlaç Turkey as of October 1, 2021...
Double success for 'Pandemic Memories'
In the "Pandemic Memories Project" 16th Felis Awards, which was implemented and continued with the unconditional support of Nobel under the leadership of the Society of Turkish Intensivists, the Health Communicat...
Signatures Have Been Signed For a Domestic Biotechnological Drug to Be Used in the Treatment of a Rare Disease
The cell developed by Izmir Biomedicine and Genome Center (IBG) and OzBio LLC will be used for the manufacturing of the drug. With the proje...
Have you visited Our Digital Platform for Healthcare Professionals, NOBELYUM?
Our digital platform NOBELYUM that we implemented as Nobel İlaç as of September, continues to provide an uninterrupted medical and scientific service to healthcare professio...
Nobel İlaç Awarded for the Second Time with the Career Prescription Internship Program
Our Career Recipe internship program was awarded in the TOP 100 Talent Program in 2021, after 2020.
Our Digital Platform for Healthcare Professionals, Nobelyum, is online
As Nobel İlaç, we launched our digital platform, which we built under the name NOBELYUM, in July and put it at the service of healthcare professionals. Providing a continuous, sust...
We become a hope for our forests. We donate a sapling for each of our domestic and foreign employees.
We are all deeply saddened by the fires in many parts of our country.
Nobels of the Year Plaques Found Their Owners
We delivered the plaques of 2019, which we could not give last year due to the pandemic, to the owners in a face-to-face ceremony on Friday, July 9, 2021.
Nobel İlaç's Rise in the Companies Ranking Continues
Nobel İlaç, which continued its rise to 239th place in the "ISO-Turkey's 500 Largest Industrial Enterprises" survey, rose 20 places to 296th place in the "Fortune 500" survey, which determines Turke...
Our virus-like particles (VLP) vaccine is in Phase II stage
COVIBEL, the innovative local Corona Virus vaccine, which is on the vaccine candidate list of the World Health Organization, produced at the biotechnological pharmaceutical raw material facil...
Nobel İlaç was among the top three pharmaceutical companies in R&D investment
The results of the research of Turkey's 250 companies with the highest R&D expenditures have been announced.
Nobel İlaç won the second prize in the “IKMIB (Istanbul Chemicals and Chemical Products Exporters Association) 2020 Stars of Exports Awards, Pharmaceutical Products” category
The export stars of 2020 were determined in the chemical industry, which mak...
